$1.550
+0.052 (+3.33%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BGLC Prediction & Forecast by Similar Chart Analysis
Alphio's BGLC stock price prediction model matches the current BioNexus Gene Lab Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.65 (+6.14%). The 1-week path is $1.50 (-3.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BioNexus Gene Lab Corp Stock?
BioNexus Gene Lab Corp (BGLC) is a good buy right now due to its recent stock surge of 82.96% after a strategic partnership announcement, indicating strong market interest. Additionally, the stock's current price of 1.55 is significantly below its 200-day moving average of 2.605, suggesting potential for recovery. However, the company has a negative net income of -286451 in the latest quarter, which remains a key risk.
BGLC stock price ended at $1.55 on Friday, after rising +3.33%
BioNexus Gene Lab Corp (BGLC) last closed at $1.55, gaining +3.33%. These facts feed the 1-day and 1-week BGLC price prediction above.
Forecast Drivers
BioNexus Gene Lab Corp (BGLC) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BGLC, ranked by similarity.
Seasonality analysis for BGLC
Historically the probability of a positive August return for BGLC is 33.33%. September offers the highest probability of a positive month at 51.22%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BGLC
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.81 | $4.55 | $4.71 | +193.66% |
| Sep 2026 | $4.79 | $5.75 | $6.85 | +271.09% |
| Oct 2026 | $5.01 | $5.13 | $5.47 | +231.09% |
| Nov 2026 | $4.33 | $5.30 | $5.48 | +241.95% |
| Dec 2026 | $5.36 | $6.16 | $7.07 | +297.31% |
In 2026, BioNexus Gene Lab Corp (BGLC) is projected to range from $3.81 to $7.07.
BioNexus Gene Lab Corp 2026 monthly forecast
In Aug 2026, BioNexus Gene Lab Corp is projected to average $4.55, with a low of $3.81 and high of $4.71.
In Sep 2026, BioNexus Gene Lab Corp is projected to average $5.75, with a low of $4.79 and high of $6.85.
In Oct 2026, BioNexus Gene Lab Corp is projected to average $5.13, with a low of $5.01 and high of $5.47.
In Nov 2026, BioNexus Gene Lab Corp is projected to average $5.30, with a low of $4.33 and high of $5.48.
In Dec 2026, BioNexus Gene Lab Corp is projected to average $6.16, with a low of $5.36 and high of $7.07.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.